LGMG in Covid-19 vaccine centre construction

By Euan Youdale15 July 2020

LGMG has assisted in the construction of the world’s first Covid-19 vaccine laboratory and production centre, in China, with a range of access equipment. 

Since the outbreak of Covid-19, countries around the world are actively responding to the outbreak and developing vaccines. The world’s first laboratory specifically for the development and production of a Covid-19 vaccine has been completed in Wuhan, China – the city in which the coronavirus first appeared.

The centre is designed to provide safe and reliable equipment for scientific research and large-scale production of a new coronavirus vaccine.

LGMG also provided access equipment for the connected Huoshenshan Hospital, which was hurriedly built earlier in the year, specifically for patients with Covid-19. “LGMG was very fortunate to participate in the construction of the institute again recently,” said a company spokesman.

Since the epidemic began, Lingong Group, which incorporates LGMG, has cooperated with distributors and rental companies throughout the country to provide support for the construction of hospitals for Covid-19.

 

Latest News
Diamond Scaffold Services retains merger-and-acquisition specialist for its sale
Southern scaffolder with a seasoned management team and solid workforce plans a sale to properly capitalize the business to continue its growth strategy
Webuild has US$12 billion Australian order backlog after acquisition
Deal means that WeBuild take on staff and order backlog from Australian engineering and construction company
Weak housing demand prompts turnaround plan for Skanska and Ikea’s modular homes arm
Weakening demand for affordable housing has prompted Skanska to launch a turnaround plan for its modular homes arm BoKlok, which it runs in partnership with Ikea.